Fred Hutchinson Cancer Center at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Fred Hutchinson Cancer Center brings 2 presentations to ESGCT 2026 in Hamburg. Its work spans measuring editing outcomes and engineering T cell receptors. Topics include single-cell sequencing that reads multiplex editing after autologous gene therapy more accurately than bulk sequencing, and gamma delta receptor chains that widen the set of targetable epitopes.
| Organization | ESGCT 2026 Attendance |
|---|---|
Fred Hutchinson Cancer Center Seattle, Washington | |
Cancer research and treatment centre whose work spans CAR-T and T cell receptor therapies, blood stem cell transplantation and stem cell gene therapy. | Poster Thu Oct 29 2:00pm–4:00pm High-throughput single cell sequencing outperforms bulk sequencing for the assessment of multiplex gene editing after autologous gene therapy in the nonhuman primate model Poster Thu Oct 29 2:00pm–4:00pm Structural features of γδ TCR chains expand targetable epitope space for chimeric T cell receptor therapy |
Instantly find 20 buyers from Fred Hutchinson Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction